In June，2017，the former National Food and Drug Administration officially became a member of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use （ICH）. In June，2018，it became a member of ICH Management Committee. This report elaborated on the historical development and reform of ICH，the process of China’s entry into ICH and its management committee，and the work and development after joining ICH，which marked an important step of China’s drug standards in the field of international cooperation. It reflected the hard work and tremendous progress made by China’s drug regulatory authorities in integrating into the international rules-making mechanism.